HER2 and Helicobacter pylori Status in Resected Gastric Cancers: A Pathological Study of a Gastroenterological Issue
Introduction: Human epidermal growth factor receptor 2 (HER2)/neu is a critical target for gastric carcinoma treatment utilizing trastuzumab. Helicobacter pylori is a well known causative agent of gastric carcinoma. Aim: To study association of HER2/neu expression with the presence of H. pylori inf...
Main Authors: | Saraswathy Sreeram, Shrijeet Chakraborti, Ramdas Naik, Debarshi Saha, Yeshwanter Radhakrishnan, Hanaganahalli Basavaiah Sridevi, Sharada Rai, Chaithra Gowthuvalli Venkataramana |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2017-10-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | http://jcdr.net/articles/PDF/10698/30910-CE(RA1)_F(GG)PF1-(MJ_PY)_PFA(VJ_AP)-1.pdf |
Similar Items
-
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
by: Atif Ali Hashmi, et al.
Published: (2018-08-01) -
Frequency of HER-2 over Expression in the Patients with Breast Cancer after Mastectomy
by: S kargar, et al.
Published: (2013-10-01) -
Immunohistochemical expression of HER2/neu in colorectal carcinoma in Erbil city, Kurdistan Region
by: Lilav Adel Kamal, et al.
Published: (2019-12-01) -
Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01) -
HER-2/neu overexpression in breast cancer
by: Rana S. Aziz, et al.
Published: (2010-10-01)